For the Quarter Ending December 2025
North America
• In USA, the Vitamin B6 Price Index fell by 22.59% quarter-over-quarter, reflecting lower ocean freight.
• The average Vitamin B6 price for the quarter was approximately USD 15885.00/MT across distributor offers.
• Vitamin B6 Spot Price softened as distributors increased offers to clear higher warehouse inventories quickly.
• Vitamin B6 Price Forecast points to downward pressure near-term unless Chinese production disruptions interrupt supply.
• Vitamin B6 Production Cost Trend showed increases, but falling freight somewhat offset higher upstream expenses.
• Vitamin B6 Demand Outlook remains steady with pharmaceutical and animal-feed procurement sustaining baseline consumption levels.
• Inventory accumulation at West Coast distributors pressured offers, amplifying Vitamin B6 Price Index declines modestly.
• Stable Chinese rates and improved vessel schedules increased availability, tempering pressure on U.S. landed quotes.
Why did the price of Vitamin B6 change in December 2025 in North America?
• Trans-Pacific freight collapsed, reducing landed costs and directly easing import price pressure in December month.
• Chinese exporters maintained steady output while increased shipments rebuilt U.S. distributor inventories, softening spot offers.
• End-user demand normalized after seasonal restocking, leaving buyers cautious and reducing urgency for spot procurement.
APAC
• In China, the Vitamin B6 Price Index fell by 22.64% quarter-over-quarter, reflecting ample exportable supply abroad.
• The average Vitamin B6 price for the quarter was approximately USD 15800.00/MT, indicating subdued procurement sentiment.
• Vitamin B6 Spot Price eased as exporters discounted FOB offers to clear rising coastal inventories promptly.
• Vitamin B6 Price Forecast implies mild near-term weakness absent Western buying restarts or domestic production curbs.
• Vitamin B6 Production Cost Trend remained muted as abundant corn-derived glucose kept conversion costs steady recently.
• Vitamin B6 Demand Outlook points to restrained procurement as downstream inventories and year-end caution limited buying.
• High inventories and softened export demand pressured the Vitamin B6 Price Index, prompting competitive FOB offers abroad.
• Major Chinese producers ran near-nameplate rates, keeping exportable supply ample and reinforcing Vitamin B6 Price Index pressure.
Why did the price of Vitamin B6 change in December 2025 in APAC?
• Ample exportable supply and ramping new capacity increased volumes, removing bid-support and pressuring FOB prices.
• Stable corn-derived feedstock costs and steady logistics prevented cost-driven inflation, enabling suppliers hold competitive offers.
• Year-end inventory management and reduced spot buying by importers removed urgency, weakening Vitamin B6 demand.
Europe
• In Germany, the Vitamin B6 Price Index fell by 22.64% quarter-over-quarter, driven by weaker Chinese export offers.
• The average Vitamin B6 price for the quarter was approximately USD 15875.00/MT, reflecting landed-cost averages in Germany.
• Germany's Vitamin B6 Spot Price declined as ample inventories and soft procurement pressure allowed deeper import discounts.
• The Vitamin B6 Price Forecast suggests recovery potential if downstream winter restocking strengthens and Chinese offers tighten.
• Vitamin B6 Production Cost Trend remains elevated for domestic conversion due to higher natural-gas and electricity tariffs.
• The Vitamin B6 Demand Outlook is steady but muted as distributors work through inventories and avoid restocking.
• Currency effects and freight stability influenced the Vitamin B6 Price Index as euro-renminbi moves raised landed costs.
• Ample Chinese export availability and normal vessel operations allowed importers to rebuild safety stocks, maintaining margin discipline.
Why did the price of Vitamin B6 change in December 2025 in Europe?
• Softer Chinese export offers and wider discounts reduced landed costs, pressuring German Vitamin B6 December assessments.
• Distributors worked through fourth-quarter inventories, avoiding restocking for financial closures, which softened German Vitamin B6 demand.
• Stable freight reduced delivery premiums, while elevated domestic conversion costs effectively limited local producers' market influence.
For the Quarter Ending September 2025
North America
• In the USA, the Vitamin B6 Price Index fell by 14.63% quarter-over-quarter, reflecting oversupply pressure.
• The average Vitamin B6 price for the quarter was approximately USD 20520/MT, per import assessments.
• Vitamin B6 Spot Price weakened as exporters cut offers to clear surplus, reducing importer inquiries.
• The Vitamin B6 Price Forecast indicates gradual stabilization as buyers resume measured procurement for production.
• Vitamin B6 Production Cost Trend remained stable, with feedstock and logistics costs showing limited movement.
• Vitamin B6 Demand Outlook stays subdued as pharmaceutical, nutraceutical buyers defer purchases, maintaining high inventories.
• Distributor stock overhang pressured the Vitamin B6 Price Index, limiting supplier scope for significant increases.
• Export inquiries were muted while strategic exporter discounts and stable logistics sustained near-term downward pressure.
Why did the price of Vitamin B6 change in September 2025 in North America?
• Persistent exporter production and aggressive offer reductions created oversupply, directly pressuring import prices and margins.
• High distributor inventories reduced procurement urgency, limiting spot buying and preventing immediate price stabilization activity.
• Logistics remained efficient with muted freight effects, while policy shifts and tariffs discouraged import commitments.
APAC
• In China, the Vitamin B6 Price Index fell by 14.55% quarter-over-quarter, driven by oversupply.
• The average Vitamin B6 price for the quarter was approximately USD 20423.33/MT reported from export transactions.
• Vitamin B6 Spot Price stayed depressed as exporters trimmed offers to clear inventories amid weak inquiries.
• The Vitamin B6 Price Forecast points to modest recovery as buyers cautiously resume procurement ahead.
• Vitamin B6 Production Cost Trend remained stable with steady feedstock supply, thus limiting pricing pressure.
• Vitamin B6 Demand Outlook remains muted across pharmaceuticals and nutraceuticals, with buyers reducing spot purchases.
• High inventories and smooth logistics weighed on the Vitamin B6 Price Index, constraining seller pricing power.
• Downstream fortified food and pediatric nutrition demand will determine Vitamin B6 Spot Price recovery speed.
Why did the price of Vitamin B6 change in September 2025 in APAC?
• Sustained production and uninterrupted plant runs generated oversupply, pressuring export offers and the spot market.
• Elevated inventories among producers and buyers reduced buying urgency, prompting discounts and inventory clearance efforts.
• Stable logistics and limited feedstock cost pressure meant prices reflected supply-demand imbalance rather than cost inflation.
Europe
• In Germany, the Vitamin B6 Price Index fell by 14.49% quarter-over-quarter, driven by weak demand.
• The average Vitamin B6 price for the quarter was approximately USD 20520/MT, reflecting lower offers.
• Exporters reduced offers, pressuring the Vitamin B6 Spot Price and Germany’s Price Index downward materially.
• Stable upstream production and feedstock availability kept the Vitamin B6 Production Cost Trend muted now.
• Elevated inventories depressed buying, constraining the Vitamin B6 Demand Outlook and limiting price recovery short-term.
• Early signs of firmer inquiry underpin a cautious Vitamin B6 Price Forecast suggesting gradual normalization.
• Importers may resume selective procurement, supporting the Vitamin B6 Price Index as inventories normalize gradually.
• Smooth logistics and stable freight kept landed costs predictable, restraining abrupt movements in Vitamin B6 Spot Price.
Why did the price of Vitamin B6 change in September 2025 in Europe?
• Oversupply from uninterrupted export production pressured import offers, increasing competitive downward pressure on landed prices.
• High domestic inventories reduced buying urgency, limiting additional demand and preventing price stabilization during September.
• Stable logistics and favorable euro exchange moderated landed costs, yet weak procurement kept price declines structurally ongoing.
For the Quarter Ending June 2025
North America
• The Vitamin B6 Spot Price in North America has witnessed a sharp decline of -5.74% in June 2025 and settled at USD 23,160/MT (CFR Los Angeles) which indicated a significant deterioration in demand-side momentum.
• Why did the price change in July 2025?
The Vitamin B6 Price Index experienced continued pressure in July due to persistent oversupply from exporting origins, high domestic inventories and cautious procurement ahead of Q3. The market saw minimal price support from downstream sectors which led to another round of competitive pricing adjustments by importers.
• Uninterrupted production at Asian manufacturing hubs and strategic offer reductions by exporters led to consistent weekly declines in the Vitamin B6 Spot Price. U.S. importers were forced to match these offers, driving down CFR values.
• Distributors in the U.S. faced elevated inventory levels through June. The downstream pharmaceutical and nutraceutical sectors operated on deferred buying patterns, waiting for Q3 to initiate new orders.
• While domestic logistics and freight rates remained stable, they had minimal impact on pricing. The Vitamin B6 Price Forecast was shaped entirely by demand inertia and importer hesitation rather than logistical or policy-driven disruptions.
• Earlier in Q2, the market saw mild upward movement of +0.74% in April and +0.78% in May, supported by stable procurement and tight inventory discipline. However, the foundation for a Q3 decline was being laid.
• No uptick in consumption trends was seen across vitamin blends, fortified food, or contract formulations. Buyers relied on inventory drawdowns rather than initiating forward stocking.
• The Vitamin B6 Price Forecast for Q3 remains soft unless there is a revival in nutraceutical or pharmaceutical sector restocking. Price floors are being tested amid intense supplier competition.
• The U.S. market’s reliance on imports from Asia leaves it vulnerable to global oversupply trends, especially when domestic buying sentiment is suppressed.
Asia Pacific
• The Vitamin B6 Spot Price in APAC (FOB Shanghai) fell by -6.05% in June 2025, closing at USD 22,970/MT, marking the steepest monthly drop in Q2 due to unrestrained output and surplus inventory.
• Why did the price change in July 2025?
The Vitamin B6 Price Index remained under pressure in July as Chinese producers continued discounting to clear high warehouse stocks. Global buyers avoided forward orders, expecting further price erosion amid continued oversupply.
• Throughout June, Chinese producers operated without interruptions, building up inventories. Weekly price cuts were deployed to prompt demand but achieved limited success.
• International and domestic buyers stayed on the sidelines, reluctant to purchase amid weekly price markdowns. No seasonal triggers or promotional cycles influenced spot demand.
• The Vitamin B6 price slide in APAC was purely market-driven, not logistical. Smooth port operations and domestic transportation facilitated exports, but the weak demand made these advantages irrelevant to price support.
• Prices saw modest gains in April (+0.75%) and May (+0.70%), driven by balanced production and consistent downstream procurement. However, this momentum reversed sharply in June.
• Despite weak maize sentiment globally, Chinese plants ran at full capacity, indicating no cost-side constraints. This ensured an uninterrupted supply glut, intensifying the price correction.
• APAC is expected to remain in a bearish posture for early Q3 unless corrective production cutbacks occur or demand revives from global formulation centers.
• With Chinese Vitamin B6 setting the global tone, FOB prices from Shanghai directly impacted CFR prices in both Europe and North America, reinforcing the interconnectedness of the supply-demand imbalance.
Europe
• The Vitamin B6 Spot Price in Europe (CFR Hamburg) dropped significantly by -5.95% in June 2025, closing at USD 23,080/MT, reflecting aggressive offshore supplier competition and stock-led demand weakness.
• Why did the price change in July 2025?
The Vitamin B6 Price Index in July further deteriorated due to persistent exporter markdowns and subdued German demand. Elevated inventories discouraged restocking, and the absence of sector-specific events meant spot purchases remained minimal.
• Consistent production at exporting origins and absence of supply-chain bottlenecks created a seller-heavy market. Importers in Germany received lower offers weekly through June, forcing downward alignment on CFR pricing.
• German importers entered June with high stock levels, dampening procurement appetite. This inventory overhang created a psychological price ceiling across the market.
• The Vitamin B6 Spot Price rose modestly in April (+0.91%) and May (+0.70%), aligned with Chinese FOB trends. But these gains were undone in June as export offers weakened and demand slowed.
• Hamburg and other entry points saw seamless operations. Inland distribution faced no hurdles, and freight fluctuations remained secondary to price war-driven supply pressure.
• The pharmaceutical and supplement markets displayed no promotional triggers or seasonal restocking needs. Contract manufacturers operated on steady consumption patterns, avoiding speculative buying.
• Price recovery in Q3 will hinge on clearing existing inventories and any surprise uptick in EU demand. For now, the trajectory points downward or flat at best.
• Europe’s Vitamin B6 market continues to shadow Asian price benchmarks, with Chinese export sentiment and biofermentation trends setting the tone for Hamburg’s price index shifts.
For the Quarter Ending March 2025
North America
During the January to March 2025 quarter, the North American Vitamin B6 market experienced a modest average price increase of about 0.51% from previous quarter. The market tone was generally steady and was driven by stable demand from pharmaceutical and personal care sectors. Seasonal change from winter to early spring supported moderate procurement activity as manufacturers planned ahead for new production cycles.
Despite a relatively calm trading environment the tariff measures on certain imported categories provided some price support for locally sourced Vitamin B6. Inventory levels remained comfortably placed, with no significant overhang from the previous quarter. This allowed Vitamin B6 suppliers and Vitamin B6 distributors to manage supply efficiently without causing sharp market reactions.
The nutraceutical segment maintained steady offtakes, whereas the food and beverage sector operated cautiously amid controlled purchasing schedules. Overall, the combination of seasonal transition and steady downstream consumption helped Vitamin B6 prices hold firm in the region. Market sentiment remained optimistic throughout the first quarter of 2025 which was supported by consistent logistics and strategic buying across key sectors.
Asia Pacific
In the first quarter of 2025, the Asia Pacific market recorded a slight rise of around 0.90% in average Vitamin B6 prices. The period was marked by moderate activity in the Vitamin B6 market, with some support coming from downstream demand in pharmaceutical and nutraceutical sectors. The seasonal transition from winter to spring played a subtle role in shifting procurement patterns. Many Vitamin B6 suppliers in the region kept inventory levels steady and avoided large stock movements during the Chinese Lunar New Year holidays, which affected overall production schedules.
Being a key exporting country, any production adjustment in China typically influences the broader Asia Pacific Vitamin B6 market sentiment. The downstream sectors saw a stable performance, though food and beverage manufacturers showed slightly cautious buying due to existing stock availability. Smooth logistics and well-managed inventory positions limited any sharp fluctuations. Anticipation of upcoming production cycles further encouraged strategic procurement by Vitamin B6 distributors. Overall, the market followed a balanced pace in the first quarter of 2025, with steady price growth reflecting well-maintained market fundamentals.
Europe
The European market saw a mild quarterly increase of around 0.37% in Vitamin B6 prices during the first quarter of 2025. The region observed steady procurement patterns from pharmaceutical and food-related sectors, whereas personal care applications remained moderately active. A balanced supply situation, combined with controlled inventory positions helped in keeping market sentiment stable.
Many Vitamin B6 distributors in the region adopted a careful procurement approach and avoided excess stock build-up while maintaining essential supplies. Although the increase was marginal, it reflected consistent demand, particularly from nutraceutical manufacturers who planned ahead for seasonal product launches.
The overall Vitamin B6 market in Europe was shaped by steady logistics and anticipation of upcoming production schedules in key manufacturing hubs. Market players responded cautiously which helped to keep price movements limited within a narrow range. The price increase aligned with soft regional demand and balanced stock levels, helping the market avoid any volatility. As downstream sectors continued routine operations in first quarter of 2025, the market kept a composed tone with suppliers managing offers in line with stable regional trends.
